Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Lilly, Boehringer slash investment plans in Germany
In response to a healthcare reform initiative in Germany, Lilly and Boehringer have slashed their planned investments there, each by at least $1B.
Kevin Dunleavy
Jun 3, 2026 3:10pm
Regulatory tracker: AbbVie, Amgen score separate EU approvals
Jun 3, 2026 2:50pm
How HER2 biology is shaping next-generation cancer treatment
Brought to you by
Jazz Pharmaceuticals
A patient-first shift in disease language and communication
Jun 3, 2026 11:35am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
Zevra CEO drafts big ambitions for Miplyffa's US adoption curve
Jun 3, 2026 11:17am
